In defense of a regulated market in kidneys from living vendors.
about
Key issues in transplant tourismExperiences of the families concerning organ donation of a family member with brain death.Regulated payments for living kidney donation: an empirical assessment of the ethical concernsFrom blood donation to kidney sales: the gift relationship and transplant commercialism.The Mississippi decision exchanging parole for kidney donation: is this the beginning of change for altruistic-based human organ donation policy in the United States?A "Queen of Hearts" trial of organ markets: why Scheper-Hughes's objections to markets in human organs fail.The "spare parts person"? Conceptions of the human body and their implications for public attitudes towards organ donation and organ salePayments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participation.Saving lives is more important than abstract moral concerns: financial incentives should be used to increase organ donation.Assessing the likely harms to kidney vendors in regulated organ markets.Black markets, transplant kidneys and interpersonal coercion.Paid organ donation.Should we pay organ donors?: Case against paying donors was a litany of errors.The Body as Gift, Commodity, or Something in Between: Ethical Implications of Advanced Kidney Donation.Imposing options on people in poverty: the harm of a live donor organ market."Living cadavers" in Bangladesh: bioviolence in the human organ bazaar.Moral repugnance, moral distress, and organ sales.Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Transplant tourism and organ trafficking: Ethical implications for the nursing profession.Using the theory of planned behavior framework for designing interventions related to organ donation.Professional obligation and supererogation with reference to the transplant tourist.Kidney Sales and Market Regulation: A Reply to Semrau.Reframing the Moral Limits of Markets Debate: Social Domains, Values, Allocation MethodsAll the More Reason: Why Julian Koplin Should Support a Trial of Incentives for Organ DonationRisk, Regulation, and Financial Incentives for Living Kidney Donation
P2860
Q28661993-7450C358-9862-4D0E-A62D-8C9074A1A3B7Q33771336-09A7CD0A-13F2-43AA-8E9D-4C13D7121E12Q33832332-D646DC49-A9FA-4DCB-A3FA-F1AEF4411B99Q34497735-CB8B965A-F79F-4539-AB9C-14FED822A2F4Q34887912-D8E91C0A-0B7B-4900-8A44-7F3FDDA90C04Q36776943-A64862D1-E25F-4750-A321-C4321C4C1C7EQ37158583-6CAC7B28-9292-4845-8A2F-B1BD4F8F3892Q37192426-D16A095D-C2B6-449B-83F2-DD4C2F93589FQ37397909-49C1A89D-8831-4B85-8563-E805FC10E055Q38250364-F96B3523-05B8-4DD4-96C0-2FE3AD8CCBE5Q41827799-015E2151-639F-4663-8F11-4A1CD8F7E577Q42154710-48CFBB33-D03E-4D4F-B7EB-FD425EF7F645Q42935970-3C0B358A-5710-46AC-B32C-1277434B591EQ46134729-585AB42C-522E-4DD1-AF99-D5DD4BD13B81Q47193532-948FC7AF-5DD0-40C8-B2D7-DC1F9AC104B4Q47204818-85550D37-649E-4E78-8675-64AEBE212511Q47418375-8D1ED4C6-85C2-4BCD-8797-849018D0BCD5Q47578488-16301F08-8CD9-4C58-9AAB-61FADDD028C2Q47695523-5F633DA6-3E8E-4E1B-8B6E-B01A69B1119BQ48139185-EC42B487-0172-498E-ADCF-EEA9EBDD624EQ48892217-5CD043CF-C739-4DF8-ACA1-0B4D4EC64DC7Q49921623-8EB6BD8F-3B5F-4964-BCEE-1FF1A0AA1D95Q57750509-EC7DE42B-605C-42CB-90FE-621249FCD8E4Q57988717-CE2BEFD3-895E-47E3-83FE-503982EBE708Q57988903-2E7CB64F-7014-456F-8AAD-E6726771D62A
P2860
In defense of a regulated market in kidneys from living vendors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In defense of a regulated market in kidneys from living vendors.
@en
type
label
In defense of a regulated market in kidneys from living vendors.
@en
prefLabel
In defense of a regulated market in kidneys from living vendors.
@en
P1476
In defense of a regulated market in kidneys from living vendors.
@en
P2093
Benjamin E Hippen
P304
P356
10.1080/03605310500421397
P577
2005-12-01T00:00:00Z